| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.8M | -12.2% |
| Cost of Revenue | $7.0M | -17.6% |
| Gross Profit | $6.8M | -5.8% |
| R&D Expense | $122K | +3.4% |
| SG&A Expense | $7.6M | -17.5% |
| Operating Income | -$470K | +78.5% |
| Pre-tax Income | -$949K | +60.5% |
| Income Tax | $9K | +212.5% |
| Net Income | -$958K | +60.0% |
| EPS (Basic) | -$0.01 | +0.0% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $402K | -23.0% |
| Inventory | $4.1M | -16.5% |
| Current Assets | $5.1M | -17.8% |
| Total Assets | $7.0M | -12.2% |
| Current Liabilities | $5.0M | -18.2% |
| Long-term Debt | $1.6M | — |
| Total Liabilities | $5.5M | -10.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$407K | +52.7% |
| Capital Expenditures | $109K | +505.6% |
| Investing Cash Flow | -$109K | -289.3% |
| Financing Cash Flow | $337K | +953.1% |
| Free Cash Flow | -$516K | +41.3% |
| $1.5M |
| -18.2% |